Nifty
Sensex
:
:
11884.50
40284.19
-10.95 (-0.09%)
-72.50 (-0.18%)

Pharmaceuticals & Drugs

Rating :
57/99

BSE: 506197 | NSE: BLISSGVS

136.70
18-Nov-2019
  • Open
  • High
  • Low
  • Previous Close
  •  139.05
  •  139.65
  •  136.00
  •  139.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  104096
  •  143.30
  •  183.70
  •  73.75

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,412.08
  • 12.99
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,407.39
  • 0.73%
  • 2.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 41.53%
  • 13.58%
  • 13.01%
  • FII
  • DII
  • Others
  • 0.62%
  • 2.91%
  • 28.35%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.71
  • 17.15
  • 4.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.21
  • 8.79
  • -4.91

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.96
  • 15.61
  • 14.68

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.73
  • 19.85
  • 19.40

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.72
  • 3.42
  • 3.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.50
  • 9.49
  • 8.24

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Net Sales
210.12
228.43
-8.02%
211.53
205.33
3.02%
244.05
167.10
46.05%
220.44
195.92
12.52%
Expenses
184.66
186.90
-1.20%
162.57
164.70
-1.29%
212.11
129.56
63.72%
176.90
147.86
19.64%
EBITDA
25.47
41.53
-38.67%
48.96
40.64
20.47%
31.94
37.53
-14.89%
43.54
48.06
-9.40%
EBIDTM
12.12%
18.18%
23.15%
19.79%
13.09%
22.46%
19.75%
24.53%
Other Income
12.90
24.88
-48.15%
2.11
13.87
-84.79%
2.79
5.54
-49.64%
-3.90
2.34
-
Interest
1.05
1.27
-17.32%
0.89
1.26
-29.37%
0.93
5.45
-82.94%
0.96
4.72
-79.66%
Depreciation
3.50
2.34
49.57%
2.77
2.21
25.34%
2.20
4.87
-54.83%
2.19
6.56
-66.62%
PBT
33.81
62.80
-46.16%
47.41
51.04
-7.11%
31.60
-1.44
-
36.48
39.12
-6.75%
Tax
2.95
21.13
-86.04%
14.04
12.06
16.42%
12.81
12.28
4.32%
9.25
13.13
-29.55%
PAT
30.86
41.66
-25.92%
33.37
38.98
-14.39%
18.79
-13.72
-
27.23
25.98
4.81%
PATM
14.69%
18.24%
15.77%
18.98%
7.70%
-8.21%
12.35%
13.26%
EPS
3.00
4.02
-25.37%
3.28
3.72
-11.83%
1.76
-1.39
-
2.50
1.74
43.68%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
886.14
898.25
814.64
798.44
546.89
407.13
344.64
396.63
267.07
218.84
Net Sales Growth
11.22%
10.26%
2.03%
46.00%
34.33%
18.13%
-13.11%
48.51%
22.04%
 
Cost Of Goods Sold
607.86
612.26
391.13
358.93
237.18
152.77
132.01
167.90
145.83
112.20
Gross Profit
278.28
285.99
423.52
439.51
309.72
254.37
212.63
228.72
121.24
106.65
GP Margin
31.40%
31.84%
51.99%
55.05%
56.63%
62.48%
61.70%
57.67%
45.40%
48.73%
Total Expenditure
736.24
740.61
617.50
595.70
391.17
303.70
273.42
285.47
195.73
160.11
Power & Fuel Cost
-
4.76
5.49
5.58
4.72
4.36
2.93
2.18
1.02
0.54
% Of Sales
-
0.53%
0.67%
0.70%
0.86%
1.07%
0.85%
0.55%
0.38%
0.25%
Employee Cost
-
42.32
69.23
61.35
33.74
29.43
23.46
15.08
6.26
3.53
% Of Sales
-
4.71%
8.50%
7.68%
6.17%
7.23%
6.81%
3.80%
2.34%
1.61%
Manufacturing Exp.
-
5.08
4.88
5.39
25.65
29.98
41.44
37.17
12.66
15.88
% Of Sales
-
0.57%
0.60%
0.68%
4.69%
7.36%
12.02%
9.37%
4.74%
7.26%
General & Admin Exp.
-
17.05
39.48
36.36
24.68
17.07
15.16
14.63
7.36
5.21
% Of Sales
-
1.90%
4.85%
4.55%
4.51%
4.19%
4.40%
3.69%
2.76%
2.38%
Selling & Distn. Exp.
-
34.73
62.09
92.46
42.51
47.05
35.12
40.26
21.13
15.75
% Of Sales
-
3.87%
7.62%
11.58%
7.77%
11.56%
10.19%
10.15%
7.91%
7.20%
Miscellaneous Exp.
-
24.41
45.21
35.63
22.71
23.03
23.30
8.25
1.47
7.01
% Of Sales
-
2.72%
5.55%
4.46%
4.15%
5.66%
6.76%
2.08%
0.55%
3.20%
EBITDA
149.91
157.64
197.14
202.74
155.72
103.43
71.22
111.16
71.34
58.73
EBITDA Margin
16.92%
17.55%
24.20%
25.39%
28.47%
25.40%
20.67%
28.03%
26.71%
26.84%
Other Income
13.90
37.63
26.54
12.51
24.35
20.29
28.00
14.07
15.75
1.87
Interest
3.83
4.41
22.80
19.69
18.61
16.41
17.98
9.72
4.03
2.15
Depreciation
10.66
8.94
21.38
20.14
13.26
11.30
10.68
6.03
3.65
5.47
PBT
149.30
181.91
179.49
175.40
148.19
96.02
70.56
109.48
79.42
52.98
Tax
39.05
55.25
56.63
62.72
48.05
34.63
29.53
49.90
26.88
12.35
Tax Rate
26.16%
30.37%
38.98%
35.76%
32.42%
36.07%
41.85%
45.58%
33.85%
23.31%
PAT
110.25
123.72
58.78
82.04
82.49
59.91
40.99
57.72
52.54
40.63
PAT before Minority Interest
108.72
126.66
88.66
112.68
100.15
61.39
41.03
59.58
52.54
40.63
Minority Interest
-1.53
-2.94
-29.88
-30.64
-17.66
-1.48
-0.04
-1.86
0.00
0.00
PAT Margin
12.44%
13.77%
7.22%
10.28%
15.08%
14.72%
11.89%
14.55%
19.67%
18.57%
PAT Growth
18.68%
110.48%
-28.35%
-0.55%
37.69%
46.16%
-28.98%
9.86%
29.31%
 
Unadjusted EPS
10.54
11.99
5.70
7.95
8.00
5.81
3.97
5.60
5.09
3.94

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
646.00
536.24
486.62
412.62
337.08
286.88
258.01
210.66
166.62
Share Capital
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
10.31
Total Reserves
635.68
525.92
476.31
402.31
326.77
276.57
247.69
200.35
156.31
Non-Current Liabilities
37.99
12.92
32.81
49.55
67.52
95.65
96.92
39.34
3.86
Secured Loans
32.54
5.92
25.58
29.62
55.03
78.80
89.97
37.63
3.65
Unsecured Loans
0.00
0.00
0.00
8.62
2.23
8.79
1.33
0.00
0.00
Long Term Provisions
1.75
1.91
2.05
1.81
1.40
1.10
0.74
0.51
0.58
Current Liabilities
207.03
299.40
437.09
378.97
242.68
307.66
202.19
59.74
42.64
Trade Payables
78.95
58.43
98.25
108.49
80.33
82.35
118.15
40.15
31.40
Other Current Liabilities
50.17
124.46
99.93
52.76
70.30
42.12
24.45
6.10
4.35
Short Term Borrowings
64.30
105.66
187.47
62.12
61.04
57.05
45.16
5.90
3.29
Short Term Provisions
13.61
10.85
51.45
155.60
31.00
126.14
14.44
7.58
3.61
Total Liabilities
904.88
860.04
1,022.90
874.24
662.17
700.35
570.92
309.74
213.12
Net Block
144.97
136.48
303.86
225.25
234.38
213.31
168.23
40.03
19.93
Gross Block
170.00
157.47
326.83
300.74
293.82
262.45
205.92
64.41
40.84
Accumulated Depreciation
25.03
20.99
22.97
75.48
59.44
49.14
37.69
24.38
20.91
Non Current Assets
211.26
170.25
456.97
291.23
244.66
229.67
219.61
100.21
56.57
Capital Work in Progress
46.74
0.47
4.03
9.10
0.00
4.33
0.65
6.91
7.55
Non Current Investment
0.72
6.30
1.05
0.11
0.01
0.01
0.01
0.00
0.00
Long Term Loans & Adv.
18.50
26.72
11.45
56.77
10.27
12.02
50.72
53.28
29.09
Other Non Current Assets
0.33
0.29
136.58
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
693.61
689.79
565.93
583.00
417.08
469.26
348.89
209.54
156.55
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.80
0.00
Inventories
77.37
59.03
49.30
38.67
33.70
32.53
32.52
12.68
11.61
Sundry Debtors
460.73
298.48
254.45
300.93
247.47
215.03
244.64
128.59
119.61
Cash & Bank
106.63
88.86
150.50
78.18
57.29
80.37
50.35
58.01
17.98
Other Current Assets
48.89
97.11
33.24
15.30
78.62
141.34
21.37
9.46
7.35
Short Term Loans & Adv.
29.49
146.30
78.44
149.92
60.69
130.30
8.92
5.09
2.62
Net Current Assets
486.59
390.39
128.84
204.03
174.40
161.60
146.70
149.80
113.91
Total Assets
904.87
860.04
1,022.90
874.23
662.17
700.35
570.91
309.75
213.12

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
39.95
17.64
289.47
112.95
48.94
41.15
6.50
35.46
0.00
PBT
181.91
179.49
175.40
148.19
96.02
70.56
109.48
79.42
0.00
Adjustment
-10.97
17.55
36.24
18.18
22.48
24.11
9.71
4.76
0.00
Changes in Working Capital
-183.07
-140.80
113.48
-8.33
-60.94
-19.30
-73.94
-37.83
0.00
Cash after chg. in Working capital
-12.13
56.24
325.13
158.05
57.56
75.36
45.25
46.35
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
52.08
-38.61
-35.66
-45.10
-8.63
-34.21
-38.75
-10.89
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-73.52
50.24
-231.25
-49.84
-38.98
-10.90
-124.05
-21.91
0.00
Net Fixed Assets
-52.48
-1.04
42.08
-5.32
-28.78
-12.86
-12.91
-16.65
Net Investments
0.16
2.37
-0.95
-1.36
0.00
-0.01
-18.19
-1.03
Others
-21.20
48.91
-272.38
-43.16
-10.20
1.97
-92.95
-4.23
Cash from Financing Activity
16.83
-75.98
-10.13
-40.25
-43.26
-8.47
109.89
26.48
0.00
Net Cash Inflow / Outflow
-16.74
-8.10
48.09
22.85
-33.31
21.77
-7.66
40.02
0.00
Opening Cash & Equivalents
36.95
47.41
0.00
5.09
49.57
27.79
58.01
17.98
0.00
Closing Cash & Equivalent
15.04
36.95
47.41
27.60
16.26
49.57
50.35
58.01
0.00

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
62.63
51.99
47.18
40.00
32.64
27.67
24.78
20.42
16.15
ROA
14.35%
9.42%
11.88%
13.04%
9.01%
6.46%
13.53%
20.09%
19.06%
ROE
21.43%
17.34%
25.06%
26.73%
19.74%
15.17%
25.56%
27.85%
24.38%
ROCE
26.58%
24.61%
31.06%
32.07%
23.57%
20.56%
36.18%
38.76%
31.53%
Fixed Asset Turnover
5.49
3.37
2.56
1.85
1.47
1.48
2.95
5.09
5.37
Receivable days
154.25
123.80
126.33
182.13
206.07
241.81
171.03
169.17
199.09
Inventory Days
27.71
24.25
20.01
24.04
29.51
34.22
20.71
16.56
19.33
Payable days
35.02
51.74
67.63
95.25
108.77
148.76
105.12
67.61
73.84
Cash Conversion Cycle
146.94
96.31
78.70
110.92
126.81
127.26
86.63
118.11
144.57
Total Debt/Equity
0.16
0.22
0.46
0.32
0.47
0.60
0.58
0.21
0.05
Interest Cover
42.21
7.37
9.91
8.96
6.85
4.92
12.27
20.70
25.67

News Update:


  • Bliss GVS Pharma - Quarterly Results
    11th Nov 2019, 21:28 PM

    Read More
  • Bliss GVS Pharma’s arm receives compliant certification from USFDA
    7th Oct 2019, 16:22 PM

    USFDA has conducted inspection at the company's facility located at M.I.D.C, Ambernath during the period June 17, 2019-June 20, 2019

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.